Crossmark

Therapeutic outcomes and predictive factors of intradetrusor onabotulinumtoxinA for neurogenic detrusor overactivity (NDO) associated with spinal cord lesion

Crossref DOI link: https://doi.org/10.1007/s11255-025-04952-x

Published Online: 2025-12-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wu, Yi-Hsuan

Chen, Sheng-Fu

Kuo, Hann-Chorng
Funding

Funding for this research was provided by:

Buddhist Tzu Chi Medical Foundation (TCMF-MP-114-02-01)
License Information

Text and Data Mining valid from 2025-12-12

Version of Record valid from 2025-12-12
More Information

Article History

Received: 16 November 2025

Accepted: 8 December 2025

First Online: 12 December 2025

Declarations

:

: The authors declare no competing interests.

: This study had approved by the Ethics Committee of Buddhist Tzu Chi Medical Foundation and Hualien Tzu Chi Hospital, coded: 114-230-B, Dated November 10, 2025.

Document is current

Any future updates will be listed below